Microcirculatory effects of intravenous fluids in critical illness: Plasma expansion beyond crystalloids and colloids

Current Opinion in Anaesthesiology

Volumn 22, Issue 2, 2009, Pages 163-167

  Villela, Nivaldo R ^a,b,e   Vázques, Beatriz Y S ^c   Intaglietta, Marcos ^d  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e Mechanical Department   (Brazil)

Author keywords

Colloidal plasma expanders; Hemodilution; Microcirculation; Plasma viscosity; Polyethylene glycolconjugated albumin

Indexed keywords

ALBUMINOID; ALGINIC ACID; DEX 70; DEXTRAN; DEXTRAN 70; HEMOGLOBIN; HETASTARCH; KERATIN; PEGYLATED ALBUMIN; PEGYLATED PROTEIN; PLASMA SUBSTITUTE; POLYSACCHARIDE; POVIDONE; RECOMBINANT PROTEIN; RINGER LACTATE SOLUTION; STARCH; UNCLASSIFIED DRUG;

ANAPHYLACTIC SHOCK; ANEMIA; BLEEDING; BLOOD TRANSFUSION; BLOOD VISCOSITY; CAPILLARY DENSITY; CAPILLARY FLOW; CLINICAL TRIAL; COLLOID; CRITICAL ILLNESS; CRYSTALLOID; DISEASE MODEL; ENDOTOXEMIA; FLUID RESUSCITATION; HEMODILUTION; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEMORRHAGIC SHOCK; HUMAN; INTRAVASCULAR HEMOLYSIS; MICROANGIOPATHY; MICROCIRCULATION; NONHUMAN; PLASMA VISCOSITY; PRIORITY JOURNAL; REVIEW;

ALBUMINS; BLOOD VISCOSITY; CAPILLARIES; COLLOIDS; CRITICAL ILLNESS; ENDOTOXEMIA; FLUID THERAPY; HEMODILUTION; HUMANS; MICROCIRCULATION; PLASMA SUBSTITUTES; PLASMA VOLUME; POLYETHYLENE GLYCOLS; SHOCK, HEMORRHAGIC;

EID: 67649548333     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328328d304     Document Type: Review

References (40)

1. Salazar Vazquez BY, Wettstein R, Cabrales P, et al. Microvascular experimental evidence on the relative significance of restoring oxygen carrying capacity vs. blood viscosity in shock resuscitation. Biochim Biophys Acta 2008; 1784:1421-1427.
2. Tsai AG, Friesenecker B, McCarthy M, et al. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skin fold model. Am J Physiol 1998; 275:H2170-H2180.
3. Mazzoni MC, Borgström P, Intaglietta M, Arfors KE. Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock 1990; 31:407-418.
4. Cryer HM, Gosche J, Harbrecht J, et al. The effect of hypertonic saline resuscitation on responses to severe hemorrhagic shock by the skeletal muscle, intestinal, and renal microcirculation systems: seeing is believing. Am J Surg 2005; 190:305-313.
5. Zakaria el R, Tsakadze NL, Garrison RN. Hypertonic saline resuscitation improves intestinal microcirculation in a rat model of hemorrhagic shock. Surgery 2006; 140:579-587; discussion 587-588.
6. Bunn F, Roberts I, Tasker R, Akpa E. Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2004:CD002045.
7. Bouskela E, Grampp W, Mellander S. Effects of hypertonic NaCl solution on microvascular haemodynamics in normo- and hypovolaemia. Acta Physiol Scand 1990; 140:85-94.
8. Cabrales P, Tsai AG, Intaglietta M. Hyperosmotic-hyperoncotic vs. hyperosmotic-hyperviscous small volume resuscitation in hemorrhagic shock. Shock 2004; 22:431-437.
9. Martini J, Cabrales PKA, Acharya SA, et al. Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective. Crit Care 2008; 12:R54. Experimental studies comparing plasma expansion using PEG-albumin with the conventional starch-based plasma expander, Voluven, predominantly used in Europe. In a shock model followed by bleeding, all individuals with PEG-albumin survived for 90 min, whereas all those receiving Voluven succumbed within 1 h.
10. 2 dissociation during 4-h hemorrhagic shock in conscious hamsters. Am J Physiol 1996; 270:H827-H836.
11. De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007; 11:R101.
12. Vincent JL, Bernard GR, Beale R, et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med 2005; 33:2266-2277.
13. Tsai AG, Acero C, Nance PR, et al. Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol 2005; 288:H1730-H1739.
14. Secomb TW, Fleishman GJ, Papenfuss HD, et al. Effects of reduced perfusion and hematocrit on flow distribution in capillary networks. Prog Appl Microcirc 1987; 12:205-211.
15. Baez S. Response characteristics of perfused microvessels to pressure and vasoactive stimuli. Angiology 1961; 12:452-461.
16. Lindbom L, Arfors KE. Mechanism and site of control for variation in the number of perfused capillaries in skeletal muscle. Int J Microcirc Clin Exp 1985; 4:121-127.
17. Cabrales P, Tsai AG, Intaglietta M. Microvascular pressure and functional capillary density in extreme hemodilution with low and high plasma viscosity expanders. Am J Physiol 2004; 287:H363-H373.
18. Cabrales P, Intaglietta M, Tsai AG. Increase plasma viscosity sustains microcirculation after resuscitation from hemorrhagic shock and continuous bleeding. Shock 2005; 23:549-555.
19. Cabrales P, Tsai AG, Intaglietta M. Hemorrhagic shock resuscitation with carbon monoxide saturated blood. Resuscitation 2007; 72:306-318. This study shows that the initial effect of a blood transfusion in treating blood losses is independent of oxygen-carrying capacity, highlighting the critical role of the viscogenic effects due to an infusion of RBCs, whether they carry or not carry oxygen.
20. Cabrales P, Tsai AG, Intaglietta M. Is resuscitation from hemorrhagic shock limited by blood oxygen-carrying capacity or blood viscosity? Shock 2007; 27:380-389.
21. Chen RYZ, Carlin RD, Simchon S, et al. Effects of dextran-induced hyperviscosity on regional blood flow and hemodynamics in dogs. Am J Physiol 1989; 256:H898-H905.
22. 2 carrier. J Cereb Blood Flow Metab 1994; 14:871-876.
23. Krieter H, Brückner UB, Kafaliakis F, Messmer K. Does colloid induced plasma hyperviscosity in haemodilution jeopardize perfusion and oxygenation of vital organs? Acta Anaesthesiol Scand 1995; 39:236-244.
24. de Wit C, Schäfer C, von Bismark P, et al. Elevation of plasma viscosity induces sustained NO-mediated dilation in the hamster cremaster microcirculation in vivo. Pflügers Arch 1997; 434:354-361.
25. Tuma R. Continuing education: the role of hemodilution in optimal patient care. Philadelphia: Temple University School of Medicine; 1989.
26. Intaglietta M. Microcirculatory effects of hemodilution: background and analysis. In: Tuma RF, White JV, Messmer K, editors. The role of hemodilution in optimal patient care. München: W. Zuckschwerdt Verlag; 1989. pp. 21-41.
27. Wang P, Chaudry IH. Crystalloid resuscitation restores but does not maintain cardiac output following severe hemorrhage. J Surg Res 1991; 50:163-169.
28. Wang P, Hauptman JG, Chaudry IH. Hemorrhage produces depression in microvascular blood flow which persists despite fluid resuscitation. Circ Shock 1990; 32:307-318.
29. Rebel A, Lenz C, Krieter H, et al. Oxygen delivery at high blood viscosity and decreased arterial oxygen content to brains of conscious rats. Am J Physiol Heart Circ Physiol 2001; 280:H2591-H2597.
30. Michelson E. Anaphylactic reaction to dextrans. N Engl J Med 1968; 278:552.
31. Ertesvåg H, Høidal HK, Schjerven H, et al. Mannurunan C-5-epimerases and their application for in vitro and in vivo design of new alginates useful in biotechnology. Metab Eng 1999; 1:262-269.
32. Cabrales P, Tsai AG, Intaglietta M. Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution. Am J Physiol 2005; 288:H1708-H1716.
33. Ewald RA, Anderson P, Williams HL, Crosby WH. Effects of intravenous infusions of feather keratin: preliminary characterization and evaluation as a plasma expander. Proc Soc Exp Biol Med 1964; 115:130-133.
34. Cabrales P, Tsai AG, Winslow RM, Intaglietta M. Extreme hemodilution with PEG-hemoglobin vs. PEG-albumin. Am J Physiol 2005; 289:H2392-H2400.
35. Kawahara NY, Ohno H. Induced thermostability of poly(ethylene oxide)-modified hemoglobin in glycols. Bioconjug Chem 1997; 8:643-648.
36. Veronese FM, Harris JM. Introduction and overview of peptide and protein pegylation. Adv Drug Deliv Rev 2002; 54:453-456.
37. Assaly RA, Dignam JD, Shapiro JI. Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction. US Patent application no. 20030004105; 2003.
38. Assaly RA, Azizi M, Kennedy D, et al. Plasma expansion by polyethyleneglycol-modified-albumin. Clin Sci 2004; 107:263-272.
39. Cabrales P, Nacharaju P, Manjula BN, et al. Early difference in tissue pH and microvascular hemodynamics in hemorrhagic shock resuscitation using polyethylene glycol-albumin- and hydroxyethyl starch-based plasma expanders. Shock 2005; 24:66-73.
40. Hangai-Hoger N, Nacharaju P, Manjula BN, et al. Microvascular effects following treatment with polyethylene glycol-albumin in lipopolysaccharide-induced endotoxemia. Crit Care Med 2006; 34:108-117.